ORTEXORTEX News
Tracking FNF? Get live short interest, options flow, and signals on ORTEX.Sign up free →
FN
Earnings PreviewFNF

FNF Options Signal Unusual Optimism Ahead of Wednesday Print

By ORTEX News · Edited by , Editor, ORTEX News2 min readdata as of 2 Aug 2026, 04:03

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

FNF heads into Wednesday's Q2 results with options traders breaking sharply from their recent defensive posture — a notable contrast to a short-selling picture that remains calm.

The most striking signal comes from the options market. Positioning has turned unusually bullish relative to recent history: the put/call ratio dropped to 0.83 on July 31, nearly 2.5 standard deviations below its 20-day average of 1.19. For most of June and early July, the PCR ran well above 1.0 — at times reaching 4-5 — reflecting heavy demand for downside protection. That hedging has been rapidly unwound, leaving the current reading as one of the most call-skewed in the past year. The stock itself has recovered 9.4% over the past month to $51.59, despite slipping fractionally on the week.

Short interest tells a straightforward, low-pressure story. Bears hold roughly 3.5% of the free float — a modest position that has edged down about 1.8% over the past week, after climbing 10.7% over the prior month. Borrow conditions are essentially frictionless: availability runs at more than 4,500% of shares short, meaning the lending pool is nowhere near tapped, and the cost to borrow, while up 67% week-on-week, remains negligible at 0.50%. There is no meaningful squeeze pressure building here.

The bull-bear debate for FNF centres on two businesses pulling in opposite directions. Bulls point to the F&G annuity segment, which posted 47% year-on-year gross sales growth to $4.4 billion last quarter, with assets under management climbing 13% to $52.2 billion — a clear bright spot. Bears focus on the Title segment, where earnings fell 38% year-on-year and pretax margins dropped well below management's stated 20% target, with a sluggish housing market and elevated mortgage rates offering little near-term relief. The mean analyst price target is $61.40 — roughly 19% above the current price — though most recent moves have been target reductions: Barclays nudged its Equal-Weight target up marginally to $51 in early July, while KBW trimmed its Outperform target to $64 from $67 in late June, and Stephens cut to $58 earlier in the spring. The direction of travel from the Street has been cautiously lower even as ratings hold.

The earnings report will test whether the F&G growth engine can keep expanding fast enough to offset a Title business that has yet to find a floor, and whether management's margin recovery narrative carries enough conviction to close the gap between the stock price and a consensus target that the Street has been steadily marking down.

Stocks in this article

See the live data behind this article on ORTEX.

Open FNF on ORTEX →

How this article was generated

Generated
2 Aug 2026, 04:21
Data as of
2 Aug 2026, 04:03
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notes

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.